Evidence map›Paper›PMID 34426566›Full record

ReviewAnnals of transplantation2021

Normothermic Machine Perfusion (NMP) of the Liver - Current Status and Future Perspectives.

Cornelius J van Beekum, Tim O Vilz, Tim R Glowka, Martin W von Websky, Jörg C Kalff, Steffen Manekeller

Open access · greenAbstract readReview
In one paragraph

Review in Annals of transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Small animalWorld journal of gastroenterology · 2026
    Review
  5. Article
  6. Article
  7. NoninvasiveTransplantation direct · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cornelius J van BeekumDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Tim O VilzDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Tim R GlowkaDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Martin W von WebskyDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Jörg C KalffDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
Steffen ManekellerDepartement of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
University Hospital Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A shortage of available organs for liver transplantation has led transplant surgeons and researchers to seek for innovative approaches in hepatoprotection and improvement of marginal allografts. The most exciting development in the past decade has been continuous mechanical perfusion of livers with blood or preservation solution to mitigate ischemia-reperfusion injury in contrast to the current standard of static cold storage. Two variations of machine perfusion have emerged in clinical practice. During hypothermic oxygenated perfusion the liver is perfused using a red blood cell-free perfusate at 2-10°C. In contrast, normothermic machine perfusion mimics physiologic liver perfusion using a red blood cell-based solution at 35.5-037.5°C, offering a multitude of potential advantages. Putative effects of normothermic perfusion include abrogation of hyperfibrinolysis after reperfusion and inflammation, glycogen repletion, and regeneration of adenosine triphosphate. Research in normothermic machine perfusion focuses on development of biomarkers predicting allograft quality and susceptibility to ischemia-reperfusion injury. Moreover, normothermic perfusion of marginal allografts allows for application of a variety of therapeutic interventions potentially enhancing organ quality. Both methods need to be subjected to translational investigation and evaluation in clinical trials. A clear advantage is transformation of an emergency procedure at night into a planned daytime surgery. Current clinical trials suggest that normothermic perfusion not only increases the use of hepatic allografts but is also associated with milder ischemia-reperfusion injury, resulting in a reduced risk of early allograft dysfunction and less biliary complications, including ischemic cholangiopathy, compared to static cold storage. The aim of this review is to give a concise overview of normothermic machine perfusion and its current applications, benefits, and possible advances in the future.

Indexed as

Liver TransplantationOrgan PreservationReperfusion InjuryAgedBiomarkersHumansLiverPerfusionBiomarkers

Identifiers

PMID34426566
PMCPMC8400594
OpenAlexW3186671937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.